Anika Therapeutics (ANIK) Change in Inventory (2010 - 2026)

Anika Therapeutics (ANIK) has 17 years of Change in Inventory data on file, last reported at $5.4 million in Q1 2026.

• On a quarterly basis, Change in Inventory rose 1133.84% year-over-year to $5.4 million in Q1 2026; TTM through Mar 2026 was $5.9 million, a 22.64% increase from a year earlier, with the FY2025 full-year figure at -$30000.0, down 100.32% from the prior year.
• Change in Inventory for Q1 2026 stood at $5.4 million, up from $1.8 million in the prior quarter.
• Over the last five years, Change in Inventory for ANIK reached as high as $5.4 million in Q1 2026 and fell as low as -$2.4 million in Q4 2024.
• Historically, Change in Inventory has averaged $1.9 million across 5 years, with a median of $2.4 million in 2022.
• Across the five-year window, Change in Inventory slumped 176.17% in 2024 and surged 1133.84% in 2026, its largest moves.
• Year by year, Change in Inventory stood at $2.9 million in 2022, then rose by 6.77% to $3.1 million in 2023, then slumped by 176.17% to -$2.4 million in 2024, then surged by 174.4% to $1.8 million in 2025, then jumped by 203.93% to $5.4 million in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were $5.4 million in Q1 2026, $1.8 million in Q4 2025, and $443000.0 in Q3 2025.